Deletion of cis-regulatory Element in FOXL2 Promoter in a Chinese Family of Type II Blepharophimosis-ptosis-epicanthus Inversus Syndrome with Polydactyly

被引:1
|
作者
Shen, Qin [1 ,2 ]
Zhao, Xiaojun [1 ,2 ]
Ji, Yongrong [1 ,2 ,3 ]
Chai, Peiwei [1 ,2 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Ophthalmol, Shanghai, Peoples R China
[2] Shanghai Key Lab Orbital Dis & Ocular Oncol, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Ophthalmol, Sch Med, Shanghai 200025, Peoples R China
基金
上海市自然科学基金;
关键词
Blepharophimosis-ptosis-epicanthus inversus syndrome; FOXL2; mutations; polydactyly; FRASER-SYNDROME; MUTATION;
D O I
10.1097/SCS.0000000000009801
中图分类号
R61 [外科手术学];
学科分类号
摘要
Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) is a relatively uncommon autosomal-dominant genetic disorder, primarily attributed to mutations in the forkhead box L2 (FOXL2) gene. Albeit the involvement of protein-coding regions of FOXL2 has been observed in the majority of BPES cases, whether deficiencies in regulatory elements lead to the pathogenesis remains poorly understood. Herein, an autosomal-dominant BPES type II family was included. Peripheral venous blood has been collected, and genomic DNA has been extracted from leukocytes. A whole exome sequencing analysis has been performed and analyzed (Deposited in NODE database: OER422653). The promoter region of FOXL2 was amplified using polymerase chain reaction (PCR). The luciferase reporter assay was performed to identify the activity of this region. In this study, we present a Chinese family diagnosed with type II BPES, characterized by the presence of small palpebral fissures, ptosis, telecanthus, and epicanthus inversus. Notably, all male individuals within the family display polydactyly. A 225-bp deletion in the 556-bp 5 ' -upstream to transcription start site of FOXL2, decorated by multiple histone modifications, was identified in affected members of the family. This deletion significantly decreased FOXL2 promoter activity, as measured by the luciferase assay. Conclusively, a novel 255-bp-deletion of the FOXL2 promoter was identified in Chinese families with BPES. Our results expand the spectrum of known FOXL2 mutations and provide additional insight into the genotype-phenotype relationships of the BPES pathogenesis. In addition, this study indicates the important role of genetic screening of cis-regulatory elements in testing heritable diseases.
引用
收藏
页码:e52 / e56
页数:5
相关论文
共 50 条
  • [1] Blepharophimosis-ptosis-epicanthus inversus syndrome caused by a 54-kb microdeletion in a FOXL2 cis-regulatory element
    Bouman, Arjan
    van Haelst, Mieke
    van Spaendonk, Rosalina
    CLINICAL DYSMORPHOLOGY, 2018, 27 (02) : 58 - 62
  • [2] FOXL2 mutations in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome
    Wang, Juan
    Liu, Jinling
    Zhang, Qingjiong
    MOLECULAR VISION, 2007, 13 (10-14): : 108 - 113
  • [3] FOXL2 mutations in Tunisian patients with blepharophimosis-ptosis-epicanthus inversus syndrome
    Kraoua, L.
    Chaabouni, M.
    Trabelsi, M.
    Chelly, I.
    Maazoul, F.
    Ben Abdallah, N.
    Boukthir, S.
    Barsaoui, S.
    Chaabouni, H.
    M'rad, R.
    CLINICAL GENETICS, 2010, 77 (06) : 601 - 603
  • [4] Pathogenic Mechanisms of Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome in a Chinese Family with a Novel Missense FOXL2 Mutation
    Yan, Yucheng
    Zhou, Lu
    Song, Peng
    Fan, Jincai
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (05): : 2591 - 2599
  • [5] FOXL2 mutations in Indian families with blepharophimosis-ptosis-epicanthus inversus syndrome
    Jeyabalan Nallathambi
    Guruswamy Neethirajan
    Kim Usha
    Jethani Jitendra
    Elfride De Baere
    Periasamy Sundaresan
    Journal of Genetics, 2007, 86 : 165 - 168
  • [6] Novel FOXL2 mutations in two Chinese families with blepharophimosis-ptosis-epicanthus inversus syndrome
    Xue, Min
    Zheng, Jie
    Zhou, Qing
    Hejtmancik, J. Fielding
    Wang, Yuan
    Li, Shouling
    BMC MEDICAL GENETICS, 2015, 16
  • [7] A Novel FOXL2 Mutation Implying Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Type I
    Li, Fang
    Chai, Peiwei
    Fan, Jiayan
    Wang, Xi
    Lu, Wenjuan
    Li, Jin
    Ge, Shengfang
    Jia, Renbing
    Zhang, He
    Fan, Xianqun
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 45 (01) : 203 - 211
  • [8] Mutation analysis of the FOXL2 gene in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome
    Tang, SJ
    Wang, XK
    Lin, LX
    Sun, Y
    Wang, YL
    Yu, HB
    MUTAGENESIS, 2006, 21 (01) : 35 - 39
  • [9] FOXL2 mutations in Indian families with blepharophimosis-ptosis-epicanthus inversus syndrome
    Nallathambi, Jeyabalan
    Neethirajan, Guruswamy
    Usha, Kim
    Jitendra, Jethani
    De Baere, Elfride
    Sundaresan, Periasamy
    JOURNAL OF GENETICS, 2007, 86 (02) : 165 - 168
  • [10] A novel FOXL2 mutation in a Chinese family with blepharophimosis, ptosis, epicanthus inversus syndrome
    Hu Tan
    Pu Yang
    Haoxian Li
    Qian Pan
    Desheng Liang
    Lingqian Wu
    Human Genome Variation, 2 (1)